Creative Biolabs Expands Services for Biotherapeutics Research

SHIRLEY, NY, September 15, 2026 /CourierPR/ -- Creative Biolabs, a research services company, has expanded its capabilities to support biotherapeutics research by integrating immunology and microfluidic solutions. As biologic modalities continue to diversify, researchers are facing increasingly complex questions surrounding immune-response characterization, functional assessment, and experimental model selection. These challenges include considerations such as complement-related effects, macrophage phenotypes, and the need for more physiologically relevant experimental models.

To address these challenges, Creative Biolabs offers a range of specialized services and customizable solutions. The company provides anticomplementary activity assays to help researchers investigate complement-related effects and generate data for biotherapeutic characterization, formulation assessment, and preclinical risk evaluation. These assays can be tailored to different research needs, enabling scientists to incorporate complement assessment into broader immunological characterization workflows based on candidate type, study design, and research objectives.

Additionally, Creative Biolabs offers a macrophage polarization assay. Macrophages play crucial roles in inflammation, tumor immunity, tissue remodeling, and responses to therapeutic intervention. Characterizing macrophage phenotypes can provide valuable insights into immune mechanisms and treatment-associated cellular responses. The company's macrophage polarization assay supports the evaluation of M1/M2-associated phenotypes and polarization-related markers under different experimental conditions. This service can assist researchers studying immunomodulatory compounds, tumor microenvironments, inflammatory mechanisms, and therapy-induced changes in macrophage function.

Creative Biolabs also provides microfluidic solutions, which expand experimental possibilities. Microfluidic technologies allow researchers to manipulate small sample volumes within precisely controlled environments. These systems can help reduce reagent consumption, support miniaturized and higher-throughput assays, and enable dynamic cellular conditions that are difficult to reproduce with conventional static culture approaches. By bringing immunological expertise and microfluidic technologies into a broader research workflow, Creative Biolabs supports investigators seeking to assess complement-related responses, characterize macrophage phenotypes, and explore miniaturized or advanced assay formats.

Creative Biolabs works with researchers to select and customize experimental strategies according to specific therapeutic modalities, biological questions, and study objectives. The combination of specialized immune assays and adaptable microfluidic technologies enables researchers to design more flexible experimental workflows for investigating complex biological interactions while balancing sample requirements, assay throughput, and data-generation needs.